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PCongenital Heart Disease
he Influence of Percutaneous
losure of Patent Ductus Arteriosus
n Left Ventricular Size and Function
Prospective Study Using Two- and Three-Dimensional
chocardiography and Measurements of Serum Natriuretic Peptides
nneli Eerola, MD, Eero Jokinen, MD, PHD, Talvikki Boldt, MD, PHD, Jaana Pihkala, MD, PHD
elsinki, Finland
OBJECTIVES We aimed to evaluate the effect of percutaneous closure of patent ductus arteriosus (PDA) on
left ventricular (LV) hemodynamics.
BACKGROUND Today, most PDAs are closed percutaneously. Little is known, however, about hemodynamic
changes after the procedure.
METHODS Of 37 children (ages 0.6 to 10.6 years) taken to the catheterization laboratory for
percutaneous PDA closure, the PDA was closed in 33. Left ventricular diastolic and systolic
dimensions, volumes, and function were examined by two-dimensional (2D) and three-
dimensional (3D) echocardiography and serum concentrations of natriuretic peptides mea-
sured before PDA closure, on the following day, and 6 months thereafter. Control subjects
comprised 36 healthy children of comparable ages.
RESULTS At baseline, LV diastolic diameter measured 2 SD in 5 of 33 patients. In 3D
echocardiography, a median LV diastolic volume measured 54.0 ml/m2 in the control subjects
and 58.4 ml/m2 (p  0.05) in the PDA group before closure and 57.2 ml/m2 (p  NS) 6
months after closure. A median N-terminal brain natriuretic peptide (pro-BNP) concentra-
tion measured 72 ng/l in the control group and 141 ng/l in the PDA group before closure
(p  0.001) and 78.5 ng/l (p  NS) 6 months after closure. Patients differed from control
subjects in indices of LV systolic and diastolic function at baseline. By the end of follow-up,
all these differences had disappeared. Even in the subgroup of patients with normal-sized LV
at baseline, the LV diastolic volume decreased significantly during follow-up.
CONCLUSIONS Changes in LV volume and function caused by PDA disappear by 6 months after
percutaneous closure. Even the children with normal-sized LV benefit from the
procedure. (J Am Coll Cardiol 2006;47:1060–6) © 2006 by the American College of
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.09.067Cardiology Foundation
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datent ductus arteriosus (PDA) causes volume overload of
he left side of the heart and predisposes the patient to
ndarteritis. Transcatheter closure of the PDA has evolved
ver the last 30 years; today, most PDAs are closed in the
atheterization laboratory. Little is known, however, of the
egree and timing of changes in left ventricular (LV) size
nd systolic and diastolic function after percutaneous PDA
losure.
Echocardiography is the most common tool for evalua-
ion of LV systolic and diastolic performance. The measures
f systolic function generally used are ejection fraction (EF)
nd fractional shortening. These measures of contractility
orrelate with the results of cardiac catheterization and
adionuclide angiography (1–3). Doppler echocardiography
llows assessment of LV inflow velocity at the level of the
From the Department of Pediatric Cardiology, Hospital for Children and Ado-
escents, University of Helsinki, Helsinki, Finland. This study was supported by
rants from the Foundation for Pediatric Research, Helsinki, Finland; the special
overnmental subsidy for health sciences research, Helsinki, Finland; and the Urho
änkänen Foundation, Lahti, Finland.L
Manuscript received July 28, 2005; revised manuscript received August 23, 2005,
ccepted October 3, 2005.itral valve (4–10). Under steady-state conditions, diastolic
elocity measurements correlate well with data from other
ethods, cardiac catheterization (8,11), radionuclide an-
iography (12), and magnetic resonance imaging (13).
hree-dimensional (3D) echocardiography is a new, non-
nvasive method to assess the LV systolic and diastolic
unction, its major advantage being independence of LV
eometry. Its results correlate closely with those of cardiac
atheterization (14), radionuclide angiography (15), and
agnetic resonance imaging (16,17). Concentrations of
lasma natriuretic peptides correlate with clinical signs and
ymptoms of congestive heart failure as well as with hemo-
ynamic measurements in children with congenital heart
isease (18,19). In adult patients, natriuretic peptides de-
rease in response to successful treatment of heart failure
20,21). To our knowledge, no reports have yet appeared
n the effect of medication or of intervention on levels
f natriuretic peptides in children with congenital heart
isease.
The purpose of the present study was to evaluate the
V size and systolic and diastolic function in children
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March 7, 2006:1060–6 Impact of PDA Closure on LV Functionefore and after PDA closure by using two-dimensional
2D) and 3D echocardiography, measurement of serum
evels of natriuretic peptides, and hemodynamic data
btained in the catheterization laboratory.
ETHODS
tudy population. At the Hospital for Children and Ad-
lescents, University of Helsinki, Finland, 38 pediatric
atients (6 months old) were diagnosed with PDA be-
ween February 2003 and March 2004. The indication for
DA closure in our institution is either systolic or contin-
ous murmur (22). On the basis of transthoracic echocar-
iography, one child was considered unsuitable for percu-
aneous closure of the PDA. The parents of the remaining
7 patients agreed to participate in the clinical trial ap-
roved by the hospital ethics committee. The control group
onsisted of 36 healthy voluntary children matched for age,
ender, height, weight, and body surface area (BSA). All
arents of participants gave their written informed consent.
For characteristics of the PDA group and the control
roup, see Table 1. All patients with PDA had either
ystolic or continuous murmur. As for the control group,
hey showed no abnormalities in clinical examination, elec-
rocardiogram, or echocardiography.
The children with PDA were taken to the cardiac
atheterization laboratory for percutaneous occlusion of the
DA. They underwent 2D and 3D echocardiography ex-
minations before catheterization. They all underwent stan-
ard hemodynamic cardiac catheterization and angiography
f the distal aortic arch. Four were found unsuitable for
atheter closure of the PDA and were scheduled for surgical
losure. They were excluded from the study. The study
roup consisted of the remaining 33 children. In this group,
ne child had clinical signs of congestive heart failure and
as treated with diuretics before PDA closure. All other
Abbreviations and Acronyms
2D  two-dimensional
3D  three-dimensional
A  atrial peak flow velocity
ANPN  N-terminal proatriopeptide
BSA  body surface area
E  early mitral peak flow velocity
EF  ejection fraction
LV  left ventricle/ventricular
PDA  patent ductus arteriosus
pro-BNP  N-terminal brain natriuretic peptide
able 1. Characteristics of Subjects in the Study Groups as Medi
Group n
Gender
(Male/Female) Age (y
atients with PDA 33 13/20 2.6 (0.9–1
ontrol subjects 36 13/23 3.3 (0.2–1SA  body surface area; PDA  patent ductus arteriosus.atients were asymptomatic. One child was diagnosed with
ulibrey nanism.
The children treated with percutaneous PDA closure
n  33) were examined on the day after the procedure and
months thereafter. The control children were examined
nce. All patients and control subjects underwent clinical
ardiovascular examination and blood test sampling for
easurement of natriuretic peptides at the time of the
chocardiographic examinations. Chest X-ray was obtained
nd cardiothoracic ratio calculated from all PDA patients at
aseline and 6 months after closure.
chocardiography. The echocardiographic examination
ook place with the patient in the supine position or in left
ateral semirecumbency. All studies were carried out by a
ingle observer (Dr. Eerola) with the Acuson Sequoia C256
chocardiography system (Siemens, Mountain View, Cali-
ornia). Data were saved on magneto-optic disks for later
nalysis. An electrocardiographic tracing was recorded si-
ultaneously with the echocardiogram. Transducer fre-
uency was 7 MHz or 5 MHz, either or both used for each
atient, to provide optimal 2D imaging and Doppler echo-
ardiographic recordings. Standard parasternal, apical, and
ubcostal views were used to detect any additional cardiac
bnormalities in the PDA group and normal cardiac anat-
my in the control group.
D echocardiography. Left ventricular diastolic function
as estimated from the mitral inflow signal obtained by
oppler echocardiography. Transmitral flow velocity patterns
ere recorded from the apical four-chamber view, with the
ample volume being positioned between the tips of the mitral
alve leaflets. We measured early peak flow velocity (E) and
trial peak flow velocity (A), and calculated E/A ratio. Areas
nder the curves of the E and A waves were measured and the
elocity integral ratio (Evti/EAvti) was calculated. In addition,
e measured the deceleration time of E velocity and deceler-
tion rate of the early diastolic flow.
We measured peak systolic flow velocity in the LV
utflow track with the apical five-chamber view and velocity
n the ascending and descending aorta with the suprasternal
iew. The LV end-diastolic and end-systolic dimensions
ere measured, and LV volumes and contractility (frac-
ional shortening and EF) were calculated by M-mode
chocardiography performed from the parasternal long-axis
iew. The z-score of LV end-diastolic dimension was
etermined (23). The mean of measurements from three
ardiac cycles for each participant was saved for analysis.
D echocardiography. Three-dimensional echocardiogra-
hy was performed with the TomTec computer software
ange)
Weight (kg) Height (cm) BSA (m2)
13.0 (6.9–32.8) 88.0 (70.0–140.5) 0.5 (0.4–1.1)
15.3 (5.4–39.2) 97.8 (56.5–146.8) 0.6 (0.3–1.3)an (R
rs)
0.6)
0.7)
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ystem. A series of cross-sectional echocardiographic images
esulted from the apical view by rotating freehand scanning.
mage acquisition was triggered by electrocardiogram. In
ree-hand scanning, a sensing device determined and regis-
ered the position and orientation of the transducer during
he acquisition process. A complete cardiac cycle of images
as taken on a selected image plane. Images of nine planes
ere collected by rotating the transducer at apical position
y hand in a semicircle of 180°. Scanning of the plane took
lace if the heart rate was within 20 beats/min of average.
igitized images were saved in the computer memory
uring acquisition. After this, the 3D dataset underwent a
ost-processing procedure.
The 3D datasets were analyzed with a detached com-
uter. Manual tracing of the endocardium was performed
n the white side of the black-white boundary. Papillary
uscles, if discontinuous with the myocardium, were in-
luded in the ventricular volume. End-diastolic volume was
alculated from the frame at the beginning of the R-wave on
he electrocardiogram or from the last frame with the mitral
alve still open. End-systolic volume was calculated from
he frame with the smallest cavity size when the mitral valve
as still closed. Time-volume curves obtained were used to
etermine end-diastolic and end-systolic volumes, stroke
olume, and EF. From the calculated first derivatives of
hese curves, we measured peak filling rate and time to peak
lling rate as indices of diastolic function and peak ejection
ate as an index of systolic function.
erum natriuretic peptides. Serum samples were frozen at
20°C. Serum concentrations of the N-terminal brain
atriuretic peptide (pro-BNP) were measured by the elec-
rochemiluminometric method. The reagent kit was manu-
actured by Roche (Mannheim, Germany), and the samples
ere analyzed at Limbach Laboratory (Heidelberg, Ger-
any). Serum concentrations of N-terminal proatriopeptide
ANPN) were measured by immunofluorometric assay. The
eagents were manufactured by Medix Biochemica (Espoo,
inland) and the instruments by Delfia Research Fluorom-
ter (Wallac, Turku, Finland).
ardiac catheterization. Children with PDA underwent
ardiac catheterization for closing the PDA with a percu-
aneous device. The procedure was performed under general
ndotracheal anesthesia, systemic heparinization, and anti-
icrobial prophylaxis with intravenous cefuroxime (30 mg/
g). The pressure and saturation measurements came from
he LV, the aortic arch, and the main pulmonary artery
efore the occlusion of the PDA. Angiography was per-
ormed in the distal aortic arch before and after PDA
cclusion. In addition, aortic pressure was measured after
cclusion.
eproducibility. Intraobserver variability was assessed in a
andomly selected subset of 12 patients by repeating all
-mode and 3D echocardiographic measurements on sep-
rate occasion. To test the interobserver variability, all
-mode measurements of 14 randomly selected patients
0
¶ere performed by a second observer (Dr. Jokinen) who was
linded to the results of the initial echocardiographic
xamination. As indices of intraobserver and interobserver
ariability, coefficient variations (mean difference  2 SD)
ere calculated.
igure 1. Left ventricular (LV) diastolic volume adjusted to body surface
rea as measured by (A) two-dimensional (2D) echocardiography and (B)
hree-dimensional (3D) echocardiography at baseline, 1 day, and 6 months
fter patent ductus arteriosus (PDA) closure in the whole PDA group and
n patients with normal-sized LV at baseline and in control group. p 
.05; †p  0.01; ‡p  0.001 as compared with control group; §p  0.05,
p  0.01 within PDA group as compared with baseline.
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March 7, 2006:1060–6 Impact of PDA Closure on LV Functiontatistical analysis. Analyses were performed with the
tatistical Package for Social Science (SPSS Inc., Chicago,
llinois). For variables derived from echocardiograms and
lood samples, mean and SD or median and range were
alculated when appropriate. Distribution of parameters
ested by Kolmogorov-Smirnov’s goodness-of-fit test was
ot normal. Therefore, the Mann-Whitney test was used
or statistical analysis between groups, and the Wilcoxon
igned rank test was used for the analysis within groups.
orrelations between the smallest diameter of the PDA,
erum concentration of pro-BNP, and LV diastolic volume
ere measured with Spearman’s correlation coefficient. The
evel of significance chosen was at p  0.05.
ESULTS
ranscatheter closure of the PDA was carried out in 33
hildren. In 10 children, the PDA was occluded with an
mplatzer PDA occlusion device (AGA, Golden Valley,
innesota) and, in 23 children, with a detachable coil
Cook, Bloomington, Indiana). No complications occurred
n the catheterization procedures. Seven children with the
mplatzer device and 19 children with a coil completed the
-month follow-up. During the follow-up, no residual
hunts were visible in the children with PDAs closed with
n Amplatzer device. Two children with PDAs occluded
ith a coil had minimal residual shunts at the time of the
-month follow-up.
aseline. In chest X-ray, cardiothoracic ratio measured a
edian 0.52 (range 0.44 to 0.71). Three patients had
ardiothoracic ratios of more than 0.60.
In 2D echocardiography, LV diastolic (Fig. 1) and
ystolic volumes adjusted to BSA were larger in the patient
roup than in the control group (Table 2). The median
-score of LV diastolic diameter was 0.75 (range 1.25 to
.75) SD in patients and 0.25 (range 1.75 to 1.25) SD
able 2. Indices of LV Systolic and Diastolic Function as Measu
easured Before PDA Closure, 1 Day, and 6 Months After the
ethod Variable Control Group
2D Diastvol/BSA (ml/m2) 62.5 (43.9–85.7)
Systvol/BSA (ml/m2) 18.2 (9.9–30.6)
E (m/s) 0.96 (0.67–1.18)
A (m/s) 0.62 (0.29–1.08)
E/A 1.50 (0.98–3.5)
E dec rate (m/s2) 9.0 (4.0–23.2)
FS (%) 40.0 (32.9–49.9)
EF (%) 72.1 (62.4–82.5)
3D Diastvol/BSA (ml/m2) 54.0 (32.6–74.4)
Systvol/BSA (ml/m2) 27.2 (14.1–42.5)
PFR (ml/s) 74.4 (20.0–166.1)
TPFR (ms) 120.5 (10.0–272.0)
PER (ml/s) 91.8 (24.5–176.9)
EF (%) 49.4 (40.5–67.1)
alues are median (range). *p  0.001, †p  0.01, §p  0.05, as compared with th
A  atrial peak flow velocity; BSA  body surface area; Diastvol/BSA  left ventriastolic flow; E/A  ratio; E  mitral early peak flow velocity; EF  ejection fraction; F
ER  peak ejection rate; PFR  peak filling rate; Systvol/BSA  left ventricular systolin control subjects. It was abnormal (2 SD) in five (15%)
atients with PDA before PDA closure and in none in the
ontrol group. Early mitral peak flow velocity (E) was
igher in the patient group (Table 2). The other indices of
iastolic function (atrial peak flow velocity (A), the E/A
atio, areas under the curves of the E and A waves or
vti/EAvti, or deceleration rate of early diastolic flow) did
ot differ from those of the control group. The LV
ractional shortening and EF were lower in the patient
roup than among control subjects (Table 2).
In 3D echocardiography, the LV diastolic (Fig. 1) and
ystolic volumes adjusted to BSA were larger in the PDA
roup (Table 2). There were no differences in systolic and
iastolic indices of LV function between the patients and
he control subjects.
Concentrations of serum natriuretic peptides were higher
n the patient group (Fig. 2). The ANPN measured 0.39
range 0.21 to 1.21) nmol/l in the PDA group and 0.31
range 0.10 to 0.77) nmol/l in the control group (p 
.007); the pro-BNP measured 141 (range 31 to 974) ng/l
nd 72 (range 27 to 321) ng/l (p  0.001), respectively. In
he patient group, the levels of pro-BNP correlated with the
-score of LV diastolic diameter (r 0.388, p 0.025) and
he diastolic LV volume adjusted to BSA by 2D echocar-
iography (r  0.404, p  0.020) but not with the smallest
iameter of the PDA.
In cardiac catheterization, before PDA closure, the
ystolic, diastolic, and mean pressures in the pulmonary
rtery measured a median 22 (range 16 to 45) mm Hg, 10
range 6 to 20) mm Hg, and 15 (range 11 to 25) mm Hg,
espectively. The LV end-diastolic pressure measured 7
range 3 to 18) mm Hg. Aortic pressures increased
ignificantly after PDA closure (Fig. 3). Before closure,
ystolic, diastolic, and mean pressures in the aortic arch
easured a median 87 (range 65 to 107) mm Hg, 48
y 2D and 3D Echocardiography in Patients With PDA
edure and in Control Subjects
PDA Group
Baseline
PDA Group
1 Day After
PDA Closure
PDA Group
6 Months After
PDA Closure
8.4 (44.7–117.1)* 80.6 (40.3–108.6)† 63.7 (37.6–89.5)‡
4.5 (12.3–45.0)* 23.5 (11.2–40.7)* 19.6 (11.9–33.3)‡
.05 (0.72–1.65)§ 0.97 (0.64–1.42) 0.97 (0.6–1.36)
0.7 (0.31–1.18) 0.65 (0.31–1.07) 0.55 (0.35–1.07)
.69 (0.87–3.55) 1.47 (0.73–3.63) 1.66 (0.94–3.12)
0.3 (5.0–28.1) 9.6 (4.1–17.4) 8.7 (4.8–15.4)‡
8.0 (28.6–50.5) 35.9 (28.9–47.4)† 36.8 (26.9–45.3)
9.2 (56.6–82.0)§ 67.2 (57.7–79.8)* 68.2 (53.9–78.0)
8.4 (37.7–99.4)§ 61.7 (43.9–99.3)† 57.2 (41.0–84.2)
0.5 (16.2–54.0) 29.1 (18.8–49.8) 27.3 (18.1–37.6)
3.2 (22.8–165.3) 88.7 (44.7–187.2) 79.0 (38.0–151.9)
9.5 (10.0–314.0) 105.0 (11.0–584.0) 115.5 (12.0–408.0)
3.8 (53.7–211.6) 108.9 (51.4–274.7)§ 94.8 (69.6–178.3)
1.7 (37.1–64.5) 52.7 (38.2–63.6)§ 53.1 (42.0–64.8)†
rol group; ‡p  0.01; p  0.05, as compared with the PDA group at baseline.
diastolic volume adjusted to body surface area; E dec rate  deceleration rate of earlyred b
Proc
7
2
1
1
1
3
6
5
3
8
11
10
5
e cont
icularS  fractional shortening; LV  left ventricular; PDA  patent ductus arteriosus;
c volume adjusted to body surface area; TPFR  time to peak filling rate.
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Impact of PDA Closure on LV Function March 7, 2006:1060–6range 26 to 61) mm Hg, and 68 (range 50 to 80) mm
g, respectively. After closure, the systolic, diastolic, and
ean pressures in the aortic arch measured a median 99
range 64 to 136) mm Hg, 58 (range 40 to 74) mm Hg,
nd 77 (range 52 to 100) mm Hg, respectively. In
igure 2. Serum concentrations of (A) N-terminal proatriopeptide (S-
NPN) and (B) N-terminal brain natriuretic peptide (S-proBNP) mea-
ured at baseline, 1 day, and 6 months after patent ductus arteriosus (PDA)
losure in the whole PDA group and in patients with normal-sized left
entricle (LV) at baseline and in control subjects. p  0.05, †p  0.01,
p  0.001 as compared with control group; §p  0.05, ¶p  0.01 within
DA group as compared with baseline.ngiography, the smallest diameter of the PDA measured
t
amedian 1.5 (range 0.9 to 3.6) mm. In the patient
ubgroup with a normal-sized LV, the PDA measured
.4 (range 0.9 to 3.6) mm. The smallest diameter of the
DA correlated with LV diastolic volume adjusted to
SA measured by 2D echocardiography (r  0.601, p 
.001), z-score of LV diastolic diameter (r  0.640, p 
.001), and LV diastolic volume adjusted to BSA mea-
ured by 3D echocardiography (r  0.382, p  0.05).
ntraobserver and interobserver variability. For LV dia-
tolic and systolic diameter and LV diastolic and systolic
olume measurements in M-mode echocardiography, the
ntraobserver variability was 2.2% (0.08  2.58), 5.1%
0.49  3.44), 5.3% (0.54  10.98), and 12.0% (1.22 
.44), respectively. For the same measurements, interob-
erver variability was 3.1% (0.41  2.38), 3.1% (0.33 
.3), 8.1% (0.58  2.24), and 6.5% (1.77  7.46),
espectively. For 3D diastolic and systolic LV volumes,
ntraobserver variability was 9.5% (0.33  6.1) and
.8% (0.80  10.74), respectively.
ay 1 after the procedure. One day after the PDA
cclusion, differences in diastolic (Fig. 1) and systolic
olumes as well as the difference in LVEF between the
DA group and control group remained significant in 2D
chocardiography (Table 2).
In 3D echocardiography, the LV diastolic volume ad-
usted to BSA remained larger (Fig. 1) and the peak ejection
ate was higher in the PDA group than in control subjects
Table 2).
Levels of serum natriuretic peptides, on the first day after
cclusion, remained higher in the PDA group than in
ontrol subjects. The serum concentration of pro-BNP had
igure 3. Aortic systolic, diastolic, and mean pressures measured in cardiac
atheterization before and after patent ductus arteriosus (PDA) closure in
he whole PDA group and in patients with normal-sized left ventricle (LV)
t baseline. ¶p  0.001 within the PDA group as compared with baseline.
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March 7, 2006:1060–6 Impact of PDA Closure on LV Functionncreased to 192 (range 17 to 1,182) ng/l (Fig. 2). The
NPN concentration measured 0.41 (range 0.16 to 1.13)
mol/l (Fig. 2).
ix months after PDA closure. At 6 months after PDA
losure, all patients were asymptomatic with no signs of
ongestive heart failure. In chest X-ray, cardiothoracic
atio measured a median 0.50 (range 0.44 to 0.73) (p 
.01 as compared with baseline). In one patient, the
ardiothoracic ratio was still more than 0.60; however, in
chocardiography, the z-score of her LV end-diastolic
iameter was 1.0 SD.
In 2D echocardiography, 6 months after PDA occlusion,
V diastolic (Fig. 1) and systolic volumes had decreased
ignificantly as compared with the baseline and did not
iffer from those in the control group (Table 2). The z-score
f LV diastolic diameter was 0.0 (range 2.0 to 1.75) SD
p  NS as compared with the control group). The differ-
nce in velocity of early mitral flow seen at baseline between
roups had disappeared. The deceleration rate of the early
iastolic flow was now lower than at baseline and did not
iffer from that in the control group (Table 2).
In 3D echocardiography, no differences appeared be-
ween groups in LV systolic and diastolic (Fig. 1) volumes
djusted to BSA (Table 2). There were no differences in
iastolic indices of LV function between patients and
ontrol subjects. The EF was higher in the patient group.
At the follow-up, serum concentrations of pro-BNP and
NPN did not differ from those in the control group (Fig.
). The pro-BNP concentration measured a median 79
range 21 to 480) ng/l in the PDA group and 72 (range 27
o 321) ng/l in the control group (p  NS); the ANPN
oncentration measured a median 0.38 (range 0.14 to 0.58)
mol/l and 0.31 (range 0.10 to 0.77) nmol/l (p  NS),
espectively.
Within the PDA group, significant changes appeared in
oth systolic and diastolic indices of LV function and in LV
ize by 2D echocardiography 6 months after PDA occlusion
s compared with baseline (Table 2): Early mitral peak flow
elocity (E), atrial peak flow velocity (A), and deceleration
ate of the early diastolic flow were lower than before the
rocedure. The LV systolic and diastolic volumes adjusted
o BSA decreased significantly during the 6-month follow-
p. Similarly, at the time of the last follow-up, the level of
ro-BNP was significantly lower than before the procedure
nd did not differ from that in the control group (Fig. 2).
Finally, even in the subgroup (n  28) with normal LV
iastolic dimensions (2 SD) at baseline, diastolic and
ystolic volumes adjusted to BSA were larger and levels of
ro-BNP and ANPN higher at baseline as compared with
he control group. All these differences had disappeared by
he time of the last follow-up (Fig. 2).
ISCUSSION
ranscatheter closure of PDA has been a feasible, effective,
nd safe procedure with good long-term results with regard to the incidence of residual shunt and complications (24–
6). Similarly, in our study, percutaneous occlusion of PDA
as a safe and effective procedure with no complications.
nly two children had a hemodynamically insignificant
inimal residual shunt 6 months after the procedure.
At baseline, in both 2D and 3D echocardiography, the
iastolic and systolic volumes adjusted to BSA were larger in
he PDA group—a difference that disappeared after closure,
ven in the patients with normal-sized LVs (Fig. 1, Table
). The smallest diameter of the PDA correlated with LV
iastolic volume adjusted to BSA. Peak filling rate, a
ensitive index of diastolic function in 3D echocardiography
27), was higher in the PDA patients at baseline, but this
ifference failed to reach statistical significance. This finding
eflects increased preload at baseline. In 2D echocardiogra-
hy, at the time of the last follow-up, 6 months after PDA
losure, mitral early peak flow velocity, atrial peak flow
elocity, and deceleration rate of the early diastolic flow had
ecreased as compared with baseline. This might reflect
ecreased flow through the mitral valve, decreased sympa-
hetic activity, and normalized LV compliance.
Levels of natriuretic peptides were significantly higher
efore PDA closure in the PDA group than in the control
roup. Pro-BNP on the first day after PDA closure was
igher than at baseline, probably due to anesthesia and
xcessive volume load caused by intravenous fluids and
ontrast media. Six months after the procedure, levels of
atriuretic peptides showed no differences between the
roups. Even in the subgroup of patients with normal-sized
Vs at baseline, the decrease in the levels of natriuretic
eptides was significant (Fig. 2). Elevated pro-BNP levels
eem to reflect volume overload of LV even in asymptomatic
atients with normal-sized LV. In the adult population,
evels of BNP vary with hemodynamic state and can serve to
eveal the effect of treatment (21). In pediatric patients,
lasma concentrations of pro-BNP correlate well with
linical signs of heart failure (19). The plasma atrial natri-
retic polypeptide concentrations correlate with hemody-
amic measurements in children with congenital heart
iseases (28). In preterm infants, the magnitude of shunting
hrough a PDA is the main determinant of plasma levels of
atriuretic peptides (29). In our study, the pro-BNP levels
orrelated with LV diastolic volume. To our knowledge, the
ffect of treatment or intervention on the levels of natriuretic
eptides has not been previously studied in a pediatric
opulation.
Harada et al. (30) have shown that the systolic and
iastolic blood pressures increase after coil occlusion of
DA, leading to increased flow volume and maximum peak
ow velocity in the left anterior descending coronary artery.
imilarly, in our study, significantly higher aortic systolic,
iastolic, and mean pressures were measured in cardiac
atheterization after PDA closure than at baseline (Fig. 3).
No correlation has been found between the presence of a
urmur and the size of the PDA (31). This might be owingo differences in the direction of ductal flow. The size and
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Impact of PDA Closure on LV Function March 7, 2006:1060–6he shape of an elastic PDA and the amount of shunting
hrough it might vary and cause more significant volume
verload of the LV than anticipated. All our patients had
ither systolic or continuous murmur. Our follow-up data
uggest that even a PDA that appears small by echocardi-
graphy might cause significant LV volume overload. In the
ubgroup of patients with normal-sized LV, the LV size and
he levels of natriuretic peptides decreased after PDA
losure. Patients with small PDAs thus need to be evaluated
arefully. They might need to be followed up and subse-
uently considered as candidates for PDA closure.
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